Non-hematologic Malignancies
2 clinical trials · Condition
◉ Watch Non-hematologic Malignancies
| Record | Firm | Date |
|---|---|---|
| A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies (NCT01705483) | Astellas Pharma Global Development, Inc. | 2012-08-28 |
| A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients (NCT00526617) | AbbVie | 2007-08-01 |
Track Non-hematologic Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.